Extract to table

04(a) provides, in relevant part, that the term "Key Person" shall mean "Marcus J

0% of the Partnership's assets under management as of the most recent quarterly valuation); and (iii) a 90-calendar-day cure period (the "Cure Period") shall commence on the Key Person Event Date, during which the General Partner may propose one or more Successor Key Persons for approval by the Limited Partners

04(c) of the A&R LPA are amended to provide that, in the event of the departure, death, permanent disability, incapacitation, or other loss of one (but not both) of the Successor Key Persons, a 180-calendar-day Replacement Period (rather than an automatic suspension of the Investment Period) shall be triggered, during which the remaining Successor Key Person and the General Partner shall identify and propose a replacement to the Limited Partners for approval

In the event of the departure, death, permanent disability, incapacitation, or other loss of both Successor Key Persons, a Key Person Event shall be deemed to have occurred, with consequences as previously provided in Section 8

The Investment Committee shall consist of: (1) Elaine R

Sato, who shall serve as Chair of the Investment Committee; (2) Jonathan K